Michele Mazzaron Castro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michele Mazzaron Castro has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
Jose E. Tanus-Santos
Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes, 3900, 14049-900 Ribeirao Preto, SP, Brazil
13 shared publicationsRaquel F. Gerlach
Department of Morphology, Estomatology and Physiology, Dental School of Ribeirao Preto, University of Sao Paulo, Av. Bandeirantes, 3900, Ribeirao Preto, SP 14049-900, Brazil
13 shared publications- Elen Rizzi
Department of Biotechnology of Medicinal Plants, University of Ribeirão Preto, Ribeirão Preto 14096-900, Brazil
12 shared publications - Carla Speroni Ceron
Department of Biological Sciences, Institute of Exact and Biological Sciences, Federal University of Ouro Preto, Ouro Preto, Brazil
8 shared publications Marcela M. Blascke de Mello
Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo
8 shared publications- Jose Eduardo Tanus-Santos
Department of Pharmacology, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil
7 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1873305
Targeting oxidative stress-MMP-2 signaling in hypertension-induced cardiovascular remodeling and dysfunction
Excessive reactive oxygen and nitrogen species contribute to maladaptive structural and functional changes in the cardiovascular system in hypertension, including extracellular matrix proteolysis, vascular smooth muscle cell proliferation and arterial stiffness. A strong link exists between oxidative stress and increased matrix metalloproteinases (MMP) activity in inflammatory cardiovascular diseases. In particular, MMP-2 plays a central role in proteolytic processes in the vasculature and heart, contributing to maladaptive remodeling and dysfunction in hypertension. Oxidative stress regulates MMP expression and activity through transcriptional, post-transcriptional and post-translational mechanisms, including pathways mediated by peroxynitrite (ONOO − )-dependent S-glutathiolation. This review provides a comprehensive overview of experimental and clinical evidence supporting the effects of enzymatic and non-enzymatic antioxidants, including dietary compounds such as polyphenols, carotenoids and vitamins, as well as pharmacological agents such as doxycycline, NADPH oxidase inhibitors, nitrite and hydrogen sulfide donors. Overall, antioxidants attenuate oxidative stress, improve nitric oxide bioavailability, reduce MMP activity and may ameliorate cardiovascular remodeling and dysfunction in experimental hypertension, although more clinical trials need to be performed to better translate such benefit effects in humans. A better understanding of antioxidant-mediated modulation of MMPs may support the development of novel therapeutic strategies to prevent or reduce hypertensive cardiovascular diseases.
- 29 July 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1873305
Open AccessTargeting oxidative stress-MMP-2 signaling in hypertension-induced cardiovascular remodeling and dysfunction
Excessive reactive oxygen and nitrogen species contribute to maladaptive structural and functional changes in the cardiovascular system in hypertension, including extracellular matrix proteolysis, vascular smooth muscle cell proliferation and arterial stiffness. A strong link exists between oxidative stress and increased matrix metalloproteinases (MMP) activity in inflammatory cardiovascular diseases. In particular, MMP-2 plays a central role in proteolytic processes in the vasculature and heart, contributing to maladaptive remodeling and dysfunction in hypertension. Oxidative stress regulates MMP expression and activity through transcriptional, post-transcriptional and post-translational mechanisms, including pathways mediated by peroxynitrite (ONOO − )-dependent S-glutathiolation. This review provides a comprehensive overview of experimental and clinical evidence supporting the effects of enzymatic and non-enzymatic antioxidants, including dietary compounds such as polyphenols, carotenoids and vitamins, as well as pharmacological agents such as doxycycline, NADPH oxidase inhibitors, nitrite and hydrogen sulfide donors. Overall, antioxidants attenuate oxidative stress, improve nitric oxide bioavailability, reduce MMP activity and may ameliorate cardiovascular remodeling and dysfunction in experimental hypertension, although more clinical trials need to be performed to better translate such benefit effects in humans. A better understanding of antioxidant-mediated modulation of MMPs may support the development of novel therapeutic strategies to prevent or reduce hypertensive cardiovascular diseases.
- 4 September 2024
- Published by Elsevier in European Journal of Pharmacology
- Vol. 983, 176981
Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension
- 4 September 2024
- Published by Elsevier in European Journal of Pharmacology
- Vol. 983, 176981
Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension
- 12 June 2024
- Published by Elsevier in Life Sciences
- Vol. 351, 122819
The hydrogen sulfide donor 4-carboxyphenyl-isothiocyanate decreases blood pressure and promotes cardioprotective effect through reduction of oxidative stress and nuclear factor kappa B/matrix metalloproteinase (MMP)-2 axis in hypertension
- 12 June 2024
- Published by Elsevier in Life Sciences
- Vol. 351, 122819
The hydrogen sulfide donor 4-carboxyphenyl-isothiocyanate decreases blood pressure and promotes cardioprotective effect through reduction of oxidative stress and nuclear factor kappa B/matrix metalloproteinase (MMP)-2 axis in hypertension
- 17 December 2022
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 396 (5) , 939-949
Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function
Oxidative stress and MMP activity are found in the hearts and arteries in hypertension and contribute to the resulting hypertrophy and dysfunction. Quercetin is a flavonoid that reduces MMP-2 activity and ameliorates hypertrophic vascular remodeling of hypertension. The hypothesis is that treatment of hypertensive rats with quercetin ameliorates coronary maladaptive remodeling and decreases hypertrophic cardiac dysfunction by decreasing oxidative stress and MMP activity. Male Sprague–Dawley two-kidney, one-clip (2K1C) and Sham rats were treated with quercetin (10 mg/kg/day) or its vehicle for 8 weeks by gavage. Rats were analyzed at 10 weeks of hypertension. Systolic blood pressure (SBP) was examined by tail-cuff plethysmography. Cardiac left ventricles were used to determine MMP activity by in situ zymography and oxidative stress by dihydroethidium. Immunofluorescence was performed to detect transforming growth factor (TGF)-β and nuclear factor kappa B (NFkB). Morphological analyses of heart and coronary arteries were done by H&E and picrosirius red, and cardiac function was measured by Langendorff. SBP was increased in 2K1C rats, and quercetin did not reduce it. However, quercetin decreased both oxidative stress and TGF-β in the left ventricles of 2K1C rats. Quercetin also decreased the accentuated MMP activity in left ventricles and coronary arteries of 2K1C rats. Quercetin ameliorated hypertension-induced coronary arterial hypertrophic remodeling, although it did not reduce cardiac hypertrophic remodeling and dysfunction. Quercetin decreases cardiac oxidative stress and TGF-β and MMP activity in addition to improving coronary remodeling, yet does not ameliorate cardiac dysfunction in 2K1C rats.
- 17 December 2022
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 396 (5) , 939-949
Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function
Oxidative stress and MMP activity are found in the hearts and arteries in hypertension and contribute to the resulting hypertrophy and dysfunction. Quercetin is a flavonoid that reduces MMP-2 activity and ameliorates hypertrophic vascular remodeling of hypertension. The hypothesis is that treatment of hypertensive rats with quercetin ameliorates coronary maladaptive remodeling and decreases hypertrophic cardiac dysfunction by decreasing oxidative stress and MMP activity. Male Sprague–Dawley two-kidney, one-clip (2K1C) and Sham rats were treated with quercetin (10 mg/kg/day) or its vehicle for 8 weeks by gavage. Rats were analyzed at 10 weeks of hypertension. Systolic blood pressure (SBP) was examined by tail-cuff plethysmography. Cardiac left ventricles were used to determine MMP activity by in situ zymography and oxidative stress by dihydroethidium. Immunofluorescence was performed to detect transforming growth factor (TGF)-β and nuclear factor kappa B (NFkB). Morphological analyses of heart and coronary arteries were done by H&E and picrosirius red, and cardiac function was measured by Langendorff. SBP was increased in 2K1C rats, and quercetin did not reduce it. However, quercetin decreased both oxidative stress and TGF-β in the left ventricles of 2K1C rats. Quercetin also decreased the accentuated MMP activity in left ventricles and coronary arteries of 2K1C rats. Quercetin ameliorated hypertension-induced coronary arterial hypertrophic remodeling, although it did not reduce cardiac hypertrophic remodeling and dysfunction. Quercetin decreases cardiac oxidative stress and TGF-β and MMP activity in addition to improving coronary remodeling, yet does not ameliorate cardiac dysfunction in 2K1C rats.
- 1 November 2021
- Published by Elsevier in Biochemical Pharmacology
- Vol. 193, 114744
MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin
- 1 November 2021
- Published by Elsevier in Biochemical Pharmacology
- Vol. 193, 114744
MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin
- 1 October 2021
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 99 (10) , 1016-1025
Inducible nitric oxide synthase (iNOS) mediates ethanol-induced redox imbalance and upregulation of inflammatory cytokines in the kidney
Overexpression of the inducible isoform of the enzyme nitric oxide synthase (iNOS) has been associated to pathological processes in the kidney. Ethanol consumption induces the renal expression of iNOS; however, the contribution of this enzyme to the deleterious effects of ethanol in the kidney remains elusive. We examined whether iNOS plays a role in the renal dysfunction and oxidative stress induced by ethanol consumption. With this purpose, male C57BL/6 wild-type (WT) or iNOS-deficient (iNOS–/–) mice were treated with ethanol (20% v/v) for 10 weeks. Treatment with ethanol increased the expression of Nox4 as well as the concentration of thiobarbituric acid reactive substances and the levels of tumor necrosis factor α in the renal cortex of WT but not iNOS–/– mice. Augmented serum levels of creatinine and increased systolic blood pressure were found in WT and iNOS–/– mice treated with ethanol. WT mice treated with ethanol showed increased production of reactive oxygen species and myeloperoxidase activity, but these responses were attenuated in iNOS–/– mice. We concluded that iNOS played a role in ethanol-induced oxidative stress and pro-inflammatory cytokine production in the kidney. These are mechanisms that may contribute to the renal toxicity induced by ethanol.
- 1 October 2021
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 99 (10) , 1016-1025
Inducible nitric oxide synthase (iNOS) mediates ethanol-induced redox imbalance and upregulation of inflammatory cytokines in the kidney
Overexpression of the inducible isoform of the enzyme nitric oxide synthase (iNOS) has been associated to pathological processes in the kidney. Ethanol consumption induces the renal expression of iNOS; however, the contribution of this enzyme to the deleterious effects of ethanol in the kidney remains elusive. We examined whether iNOS plays a role in the renal dysfunction and oxidative stress induced by ethanol consumption. With this purpose, male C57BL/6 wild-type (WT) or iNOS-deficient (iNOS–/–) mice were treated with ethanol (20% v/v) for 10 weeks. Treatment with ethanol increased the expression of Nox4 as well as the concentration of thiobarbituric acid reactive substances and the levels of tumor necrosis factor α in the renal cortex of WT but not iNOS–/– mice. Augmented serum levels of creatinine and increased systolic blood pressure were found in WT and iNOS–/– mice treated with ethanol. WT mice treated with ethanol showed increased production of reactive oxygen species and myeloperoxidase activity, but these responses were attenuated in iNOS–/– mice. We concluded that iNOS played a role in ethanol-induced oxidative stress and pro-inflammatory cytokine production in the kidney. These are mechanisms that may contribute to the renal toxicity induced by ethanol.
- 1 March 2020
- Published by Elsevier in Life Sciences
- Vol. 244, 117153
Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats
- 1 March 2020
- Published by Elsevier in Life Sciences
- Vol. 244, 117153
Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats